In situ forming implants, defined as liquid formulations that generate solid or semisolid
depots following administration, have shown a range of advantages in drug delivery. This …

Peptides take on an increasingly important role as therapeutics in areas including diabetes,
oncology, and metabolic, cardiovascular, and infectious diseases. In addition, many …

Upon publication of the first edition of Therapeutic Peptides and Proteins ten years ago there
were only 19 biotechology medicines on the market. Currently there are more than 100, with …

The need for more efficient drug delivery strategies to treat resilient diseases and the rise of
micro and nanotechnology have led to the development of more sophisticated drug …

Recent advances in life science technology have prompted the need to develop
microcapsule delivery systems that can encapsulate many different functional or active …

Camurus' FluidCrystal® injection depot is a lipid liquid crystal (LLC) phase formation-based
method, comprising of glycerol dioleate (GDO) and soy phosphatidylcholine (SPC), together …

The current study aims to develop in-situ forming implants (ISFI) of anti-psychotic risperidone
to customize schizophrenia therapy. Non-adherence to treatment is the most prevalent …

Among the various methods used to produce microparticles, electrospraying is becoming
increasingly popular, and it has the advantage of control over the size, shape and …

An in-situ forming implant formulation of naltrexone (NTX) was achieved based on a
minimum initial burst release of NTX in the in-vitro release medium using a Box-Behnken …

Purpose In situ-forming gels (semi-solid state)(ISFGs) are widely used as sustained drug
delivery, but they show a high burst release as well. The purpose of the current study is to …